Gene Kim
Keine laufenden Positionen mehr
Karriereverlauf von Gene Kim
Ehemalige bekannte Positionen von Gene Kim
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| KALEIDO BIOSCIENCES, INC. | Corporate Officer/Principal | 01.05.2018 | 01.01.2020 |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | 01.11.2013 | 01.05.2018 |
| DYNE THERAPEUTICS, INC. | Director of Finance/CFO | 01.01.2020 | - |
Ausbildung von Gene Kim
| University of California, Los Angeles | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Corporate Officer/Principal | 2 |
| Director of Finance/CFO | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| DYNE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | Health Technology |
